Comfort First Phthalimidinoglutarimide-5'-c7-oh Next Gen [xN4PHJWv]

Comfort First Phthalimidinoglutarimide-5'-c7-oh Next Gen [xN4PHJWv]: A Versatile Building Block for Targeted Protein Degradation

Comfort First Phthalimidinoglutarimide-5'-c7-oh Next Gen [xN4PHJWv] is a highly specialized degrader building block designed for targeted protein degradation. This innovative compound features an E3 ligase ligand with a linker and a functional group, making it an ideal choice for researchers seeking to conjugate target protein ligands through straightforward chemical reactions. Its unique structure allows for efficient and selective degradation of specific proteins, making it a powerful tool in the field of drug discovery and biotechnology.

Product Specifications and Technical Details

Comfort First Phthalimidinoglutarimide-5'-c7-oh Next Gen [xN4PHJWv] boasts a molecular formula of C20H26N2O4 and a molecular weight of 358.438. The compound is available with a purity of >= 95% (HPLC), ensuring reliable and consistent results in your experiments. The SMILES notation for this compound is OCCCCCCCC1=CC=C2C(=O)N(CC2=C1)C1CCC(=O)NC1=O. It is important to note that this product is shipped at room temperature and should be stored refrigerated to maintain its stability and effectiveness. With a shelf life of 12 months after the date of delivery, Comfort First Phthalimidinoglutarimide-5'-c7-oh Next Gen [xN4PHJWv] is a reliable and long-lasting investment for your research endeavors.

Applications and Benefits

Comfort First Phthalimidinoglutarimide-5'-c7-oh Next Gen [xN4PHJWv] is a versatile tool for researchers in various fields, including drug discovery, biotechnology, and medicinal chemistry. Its ability to conjugate target protein ligands through simple chemical reactions makes it particularly useful for developing novel therapeutic agents and understanding protein function. This compound is also beneficial for studying protein-protein interactions and for the development of diagnostic tools. By using Comfort First Phthalimidinoglutarimide-5'-c7-oh Next Gen [xN4PHJWv], researchers can achieve targeted protein degradation with precision, leading to advancements in the treatment of diseases and the improvement of healthcare outcomes.